Medtronic and Samsung Electronics has announced a partnership to improve diabetes management for the millions of people at risk and currently living with the disease. Both the companies are combining their respective strengths to develop a range of future solutions that will enhance the way people with diabetes live their lives, from remotely viewing diabetes data to ultimately integrating mobile and wearable devices into diabetes management systems.

The partnership, announced at the American Diabetes Association 75^th Scientific Sessions. It will combine Samsung's deep understanding of consumer mobile technology to deliver secure and convenient access to Medtronic's integrated diabetes management systems that provide clinically-proven outcomes.

"By addressing more of the social and emotional aspects of living with diabetes and improving lifestyle fit, we believe that more people worldwide will be able to experience better diabetes control that today's advanced therapies provide. Medtronic aims to transform diabetes by providing world-class integrated care, enabled by leading technologies, big data, and informatics. Our partnership with Samsung is a key step in providing convenient and discreet access to diabetes data, so together we can provide people with diabetes greater freedom and better health," said Mr Alejandro Galindo, vice-president and general manager of the Intensive Insulin Management business at Medtronic.

"Samsung is committed to applying its deep understanding of how people use technology to bring new innovations to healthcare. Patients are seeking better ways not only to monitor their condition, but also to enjoy a greater quality of life. We are excited to partner with Medtronic to develop diabetes management solutions that produce positive change and greater autonomy for people living with diabetes," said Dr David Rhew, chief medical officer and head of Healthcare and Fitness for Samsung Electronics America.

The partnership's first project focuses on delivering more discreet and convenient access to personal diabetes data by developing mobile applications optimized for Samsung mobile devices that will enable the viewing of insulin pump and continuous glucose monitoring (CGM) information. This application will work with Medtronic's MiniMed Connect product, which provides easy access to important diabetes information for people with diabetes as well as remote alerts for their loved ones, and is expected to be available in the United States later this year.

In addition, MiniMed Connect provides healthcare providers with more frequent and convenient access to their patients' insulin pump and CGM via mobile connectivity so they can adjust care plans. Through this partnership, the MiniMed Connect will ultimately be available to more people worldwide, since close to 80 percent of mobile phone users utilize the Android operating system globally.